Dr Alexander is a Senior Pharmacist and Research Fellow at Peter MacCallum Cancer Centre. She has been recognised as an emerging leader in pharmacy and cancer research, with leadership appointments including Manager of the Peter Mac Pharmacy Research Program (2017), Grade 4 pharmacist appointment (2018, advanced practitioner according to Victorian EBA), Scientific Advisory Committee of the Society of Hospital Pharmacists of Australia (SHPA) National Translational Research Collaborative (2018-2019), Board member of the International Society of Oncology Pharmacy Practitioners (ISOPP, 2016-ongoing), and Honorary Research Fellow of the Sir Peter MacCallum Department of Oncology The University of Melbourne (2018-ongoing).
Her research interests are focused on personalised and risk-adapted therapies including primary clot prevention during anticancer therapy, precision dosing of anticancer therapies, and outcomes among patients with thoracic malignancies treated with targeted and non-targeted cancer therapeutics. She currently hold research fellowships awarded by the Victorian Cancer Agency and Peter Mac Foundation.
Find out more about Marliese Alexander's experience
Marliese Alexander's highlights
FEATURED Journal article
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma
Read moreMarliese Alexander's selected work
Personalised Risk-Directed Clot Prevention For Patients With Cancer
Research Grant
Value of Precision Medicine in AdvancedNon-SmallCell Lung Cancer:Real-WorldOutcomes Associ..
Journal article
Towards Precision Medicine For The Prevention Of Cancer-Associated Thromboembolism
Research Grant
Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer
Journal article
Evaluation of an artificial intelligence clinical trial matching system in Australian lung..
Journal article
Educational needs of oncology pharmacists: A survey by the International Society of Oncolo..
Journal article
Marliese Alexander's selected work
Projects
Displaying the 2 most recent projects by Marliese Alexander.
Additional Information
FELLOWSHIP AND GRANT FUNDING Peter MacCallum Cancer Foundation Endowment Fund Grant “Australian registry for ROS1 rearranged non-small cell lung cancer - a framework for prospective collection of clinical data and consent to access biospecimens” ($36k 2019-2020, PI) Victorian Cancer Agency Early Career Health Services Research Fellowship “Towards precision medicine for the prevention of cancer-associated thromboembolism” ($300,000 – 2018-2020, CIA) International Society of Oncology Pharmacy Practitioners Research Grant “Targeted thromboprophylaxis for cancer patients at high risk of thromboembolism” (
0,000 – 2017-2018, CIA) Peter MacCallum Cancer Centre Clinician-Researcher Fellowship “A prospective randomised controlled pilot study to determine the efficacy and safety of targeted thromboprophylaxis in adult ambulatory care cancer patients at high risk of thromboembolism” ($33,000 per year for 3 years 2017-2020, CIA) Cancer Council Victoria Summer Student Scholarship Program “Infective outcomes with subcutaneous versus intravenous formulations of trastuzumab and rituximab for the treatment of cancer: A systematic review and meta-analysis (,800 to fund student for six week research placement 2018, Primary Supervisor) Cancer Council Victoria Summer Student Scholarship Program “Cardiac monitoring practices and outcomes for patients undergoing treatment with cardiotoxic cancer agents, including anthracyclines and HER-2 targeted agents” (,800 to fund student for six week research placement 2017, Primary Supervisor) Monash University Australian Post Graduate Award “Overall survival and thromboembolic risk prediction in Non-Small Cell Lung Cancer” ($25,000 per year for 3 years 2014-2017, PhD) COVIDIEN VTE Management and Prevention Scholarship Program “Thrombogenic risk profiling of lung cancer patients” ($20,000 – 2013, Co-I) Victorian Department of Health Project Grant “A preliminary report to inform the development of a state-wide Victorian framework for access to specialist cancer clinics and chemotherapy day services” (10,000 – 2014-2015, Co-I) Western and Central Melbourne Integrated Caner Service Project Grant “Development and promulgation of safe handling and distribution guidelines for “new” anticancer molecules by hospital personnel including pharmacy, nursing and medical personnel” ($80,000 – 2013-2014, Co-I)Scholarly Works
Displaying the 42 most recent scholarly works by Marliese Alexander.
Keyword Analysis
Honours, Awards and Fellowships
Finalist - Public Health Researcher
Lea Medal for Excellent Emerging Women Researchers
Minister for Health's Award for Excellence in Cancer Care (team award, surgical thromboembolism prevention)
Australian Post Graduate Award
Credentials
Positions
Positions
Honorary
The Sir Peter Maccallum Department Of Oncology
Board Member
International Society of Oncology Pharmacy Practitioners (ISOPP)
Survey Research Advisory Group 2016/Current, General Member 2013/Current
Clinical Oncological Society of Australia (COSA)
General Member
International Association for the Study of Lung Cancer
National Translational Research Collaborative Scientific Advisory Committee 2018/19; General Member 2010/Current
Society of Hospital Pharmacists of Australia (SHPA)
Education
Education
Data Science Specialisation
University of California Los Angeles
Doctor of Philosophy
Monash University
Master of Public Health
Monash University
Graduate Certificate Pharmacy Practice
Monash University
Bachelor of Pharmacy (Honours)
La Trobe University